Brunei vs South Asia (IDA & IBRD): Immunization, measles second dose
Brunei
99.0%
in 2024
South Asia (IDA & IBRD)
92.2%
in 2024
Brunei rank
1st
South Asia (IDA & IBRD) rank
3rd
Immunization, measles second dose over time
- Brunei
- South Asia (IDA & IBRD)
How they compare
Brunei currently reports 99.0% against 92.2% in South Asia (IDA & IBRD), a difference of 6.8%.
That makes Brunei's figure about 1.1 times South Asia (IDA & IBRD)'s.
Across all 25 years both countries report, Brunei has been ahead every year.
Brunei ranks 1st and South Asia (IDA & IBRD) ranks 3rd of 178 countries.
Brunei has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Brunei | South Asia (IDA & IBRD) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 94.9% | 1.0% | 93.9% | Brunei |
| 2010s | 95.8% | 57.5% | 38.3% | Brunei |
| 2020s | 98.6% | 87.8% | 10.8% | Brunei |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, measles second dose, Brunei or South Asia (IDA & IBRD)?
- Brunei, at 99.0% against 92.2% in South Asia (IDA & IBRD) as of 2024.
- What is the difference in immunization, measles second dose between Brunei and South Asia (IDA & IBRD)?
- 6.8%, with Brunei ahead.
- How many years of comparable data are there for Brunei and South Asia (IDA & IBRD)?
- 25 years are reported by both, from 2000 to 2024.
- How do Brunei and South Asia (IDA & IBRD) rank globally for immunization, measles second dose?
- Brunei ranks 1st and South Asia (IDA & IBRD) ranks 3rd of 178 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, measles second dose (% of children by the nationally recommended age). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.